DDP4 inhibitors as novel agents in improving survival in diabetic patients with CRC and lung cancer: A SEER-Medicare study. Article

Full Text via DOI: 10.1200/JCO.2019.37.15_suppl.e14633 Web of Science: 000487345800728

Cited authors

  • Bishnoi, Rohit; Hong, Young-Rock; Shah, Chintan; Ali, Azka; Skelton, William Paul; Huo, Jinhai; Dang, Nam H.; Dang, Long H.

Publication date

  • 2019

Published in

International Standard Serial Number (ISSN)

  • 0732-183X


  • 37


  • 15